Acer therapeutics inc. reports earnings results for the third quarter ended september 30, 2019

Acer therapeutics inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 5.362 million compared to usd 4.107 million a year ago. net loss was usd 5.251 million compared to usd 3.965 million a year ago. basic loss per share was usd 0.52 compared to usd 0.43 a year ago. for the nine months, operating loss was usd 24.705 million compared to usd 13.014 million a year ago. net loss was usd 24.261 million compared to usd 12.784 million a year ago. basic loss per share was usd 2.4 compared to usd 1.59 a year ago.
ACER Ratings Summary
ACER Quant Ranking